Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
UAE recalls some Nestle infant formula products, Qatar warns consumers - 2Help Your Efficiency: 10 Authoritative Apparatuses to Attempt
- 3Comet C/2025 K1 (ATLAS) breaks apart in incredible telescope photos
- 4I traveled to 13 countries in 2025. This small island nation surprised me the most.
- 5Nestlé recalls infant formula in 49 countries. See list.
- Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
- Kidneys from Black donors are more likely to be thrown away − a bioethicist explains why
- 5 things for parents to know about changes to kids vaccine schedule
- Manual for Famous Beverages 2024
- Fundamental Home Items Each Animal person Needs
- 'We need everyone,' wounded reservist urges Knesset panel to advance haredi draft law
- White House responds to Sabrina Carpenter after pop star slams 'evil' ICE video using her song
- Easter Island quarry reveals how Polynesians made enigmatic stone statues
- Cyber Monday 2025: Save over 70% on HBO Max with this Prime Video streaming deal
